Related references
Note: Only part of the references are listed.FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Xiaoxin X. Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Farnesoid X receptor modulators 2014-present: a patent review
Valentina Sepe et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-κB Signaling, and Hepatic Inflammation
Zhibo Gai et al.
MOLECULAR PHARMACOLOGY (2018)
Farnesoid X receptor is essential for the survival of renal medullary collecting duct cells under hypertonic stress
Sujuan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Vascular liver lesions: contemporary views on long-recognized entities
Christine Sempoux et al.
VIRCHOWS ARCHIV (2018)
Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis
Toshihiro Goto et al.
SCIENTIFIC REPORTS (2018)
Farnesoid X receptor agonist obeticholic acid inhibits renal inflammation and oxidative stress during lipopolysaccharide-induced acute kidney injury
Jin-Bo Zhu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Insights into hepatic and renal FXR/DDAH-1/eNOS pathway and its role in the potential benefit of rosuvastatin and silymarin in hepatic nephropathy
Yosra M. Magdy et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
Dihydroartemisinin counteracts fibrotic portal hypertension via farnesoid X receptor-dependent inhibition of hepatic stellate cell contraction
Wenxuan Xu et al.
FEBS JOURNAL (2017)
Clinical significance of farnesoid X receptor expression in thyroid neoplasia
Constantinos Giaginis et al.
FUTURE ONCOLOGY (2017)
A dual agonist of farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5, INT-767, reverses age-related kidney disease in mice
Xiaoxin X. Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis
Paolo Comeglio et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic Nephropathy
Andi Marquardt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Farnesoid X receptor regulates the growth of renal adenocarcinoma cells without affecting that of a normal renal cell-derived cell line
Tomofumi Fujino et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2017)
Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice
Jianshu Gao et al.
MOLECULAR MEDICINE REPORTS (2017)
Protective effects of dioscin against doxorubicin-induced nephrotoxicity via adjusting FXR-mediated oxidative stress and inflammation
Yimeng Zhang et al.
TOXICOLOGY (2017)
Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage
Zhibo Gai et al.
SCIENTIFIC REPORTS (2017)
NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway
Zhibo Jin et al.
CELL AND TISSUE RESEARCH (2017)
High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma
C. Giaginis et al.
NEOPLASMA (2017)
Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice
Zhibo Gai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Role of Bile Acid-Regulated Nuclear Receptor FXR and G Protein-Coupled Receptor TGR5 in Regulation of Cardiorenal Syndrome (Cardiovascular Disease and Chronic Kidney Disease)
Moshe Levi
HYPERTENSION (2016)
Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice
Young Sun Kang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2016)
Activation of farnesoid X receptor downregulates visfatin and attenuates diabetic nephropathy
Baoshang Zhou et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Amelioration of anti-tuberculosis drug induced oxidative stress in kidneys by Spirulina fusiformis in a rat model
Sherry Joseph Martin et al.
RENAL FAILURE (2016)
Uninephrectomy-Induced Lipolysis and Low-Grade Inflammation Are Mimicked by Unilateral Renal Denervation
Denis Arsenijevic et al.
FRONTIERS IN PHYSIOLOGY (2016)
Activation of FXR protects against renal fibrosis via suppressing Smad3 expression
Kai Zhao et al.
SCIENTIFIC REPORTS (2016)
Negative feedback regulation of bile acid metabolism: Impact on liver metabolism and diseases
John Y. L. Chiang
HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity
Sarah J. Glastras et al.
NUTRITION & METABOLISM (2015)
Genome-wide profiling to analyze the effects of FXR activation on mouse renal proximal tubular cells
Ting Gui et al.
GENOMICS DATA (2015)
Elevated Farnesoid X Receptor (FXR) and Retinoid X Receptors (RXRs) expression is associated with less tumor aggressiveness and favourable prognosis in patients with pancreatic adenocarcinoma
C. Giaginis et al.
NEOPLASMA (2015)
Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney
Zhibo Gai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Farnesoid X Receptor Ligand Prevents Cisplatin-Induced Kidney Injury by Enhancing Small Heterodimer Partner
Eun Hui Bae et al.
PLOS ONE (2014)
Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice
Xiaoyan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Regulation of N-Myc downstream regulated gene 2 by bile acids
Cedric Langhi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Acids Trigger Cholemic Nephropathy in Common Bile-Duct-Ligated Mice
Peter Fickert et al.
HEPATOLOGY (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats
Yohannes T. Ghebremariam et al.
PLOS ONE (2013)
Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition
Martina Duefer et al.
DIABETES (2012)
Effect of Chenodeoxycholic Acid on Fibrosis, Inflammation and Oxidative Stress in Kidney in High-Fructose-Fed Wistar Rats
Zhijuan Hu et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
Inflammation in Diabetic Nephropathy
Andy K. H. Lim et al.
MEDIATORS OF INFLAMMATION (2012)
Chapter 3: Management of progression and complications of CKD
Kidney International Supplements (2012)
Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Janne Prawitt et al.
DIABETES (2011)
Acute Doxorubicin Toxicity Differentially Alters Cytochrome P450 Expression and Arachidonic Acid Metabolism in Rat Kidney and Liver
Beshay N. M. Zordoky et al.
DRUG METABOLISM AND DISPOSITION (2011)
Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease
Jiao Mu et al.
JOURNAL OF NEPHROLOGY (2011)
The bile acid sensor FXR regulates insulin transcription and secretion
Barbara Renga et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Farnesoid X Receptor Activation Prevents the Development of Vascular Calcification in ApoE-/- Mice With Chronic Kidney Disease
Shinobu Miyazaki-Anzai et al.
CIRCULATION RESEARCH (2010)
Diabetic Nephropathy Is Accelerated by Farnesoid X Receptor Deficiency and Inhibited by Farnesoid X Receptor Activation in a Type 1 Diabetes Model
Xiaoxin X. Wang et al.
DIABETES (2010)
The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity
Iuliana Ristea Popescu et al.
FEBS LETTERS (2010)
Chronic stimulation of farnesoid X receptor impairs nitric oxide sensitivity of vascular smooth muscle
Taiki Kida et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Discovery of XL335 (WAY-362450), a Highly Potent, Selective, and Orally Active Agonist of the Farnesoid X Receptor (FXR)
Brenton Flatt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Coordinated Regulation of Dimethylarginine Dimethylaminohydrolase-1 and Cationic Amino Acid Transporter-1 by Farnesoid X Receptor in Mouse Liver and Kidney and Its Implication in the Control of Blood Levels of Asymmetric Dimethylarginine
Jiang Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Philippe Lefebvre et al.
PHYSIOLOGICAL REVIEWS (2009)
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria
Xiaoxin X. Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray
Hiroyuki Higashiyama et al.
ACTA HISTOCHEMICA (2008)
Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity
Karsten Sydow et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
Cedric Langhi et al.
FEBS LETTERS (2008)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
FXR-mediated regulation of eNOS expression in vascular endothelial cells
Jiang Li et al.
CARDIOVASCULAR RESEARCH (2008)
Farnesoid X receptor ligands inhibit vascular smooth muscle cell inflammation and migration
Yoyo T. Y. Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy
Tao Jiang et al.
DIABETES (2007)
Cisplatin nephrotoxicity: A review
Xin Yao et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2007)
Nuclear receptors in human immune cells: Expression and correlations
Andrea B. Schote et al.
MOLECULAR IMMUNOLOGY (2007)
Expression in human trophoblast and choriocarcinoma cell lines, BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like excretory function of the placenta
M. A. Serrano et al.
PLACENTA (2007)
The expression profiles of nuclear receptors in the developing and adult kidney
Jae Mi Suh et al.
MOLECULAR ENDOCRINOLOGY (2006)
Renal fibroblasts and myofibroblasts in chronic kidney disease
Frank Strutz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Effects of chenodeoxycholic acid and deoxycholic acid on cholesterol absorption and metabolism in humans
Yanwen Wang et al.
TRANSLATIONAL RESEARCH (2006)
Coordinated induction of bile acid detoxification and alternative elimination in mice:: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids
G Zollner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Regulation of the mouse organic solute transporter α-β, Ostα-Ostβ, by bile acids
T Frankenberg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-α and -β genes
JF Landrier et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells
FT He et al.
CIRCULATION RESEARCH (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine
H Lee et al.
JOURNAL OF LIPID RESEARCH (2006)
Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST alpha-OST beta in cholestasis in humans and rodents
James L. Boyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
OSTα-OSTβ:: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia
N Ballatori et al.
HEPATOLOGY (2005)
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway
T Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of carbohydrate metabolism by the farnesoid X receptor
KR Stayrook et al.
ENDOCRINOLOGY (2005)
Expression and activation of the farnesoid X receptor in the vasculature
D Bishop-Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine
G Zollner et al.
JOURNAL OF HEPATOLOGY (2003)
Identification of gene-selective modulators of the bile acid receptor FXR
I Dussault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus
LJ Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor
ST Hwang et al.
GASTROENTEROLOGY (2002)
Share Paper
